Howe & Rusling’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Buy
3,472
+84
+2% +$6.13K 0.02% 273
2026
Q1
$221K Buy
3,388
+1
+0% +$74 0.01% 283
2025
Q4
$268K Buy
3,387
+93
+3% +$7.12K 0.02% 260
2025
Q3
$240K Sell
3,294
-67
-2% -$4.91K 0.02% 266
2025
Q2
$255K Buy
3,361
+5
+0.1% +$354 0.02% 253
2025
Q1
$255K Buy
3,356
+90
+3% +$6.7K 0.02% 235
2024
Q4
$216K Sell
3,266
-92
-3% -$6.44K 0.02% 249
2024
Q3
$234K Buy
+3,358
New +$202K 0.02% 234

Other funds holding SOLV

Howe & Rusling's SOLV Position: Q2 2026 in Review

Howe & Rusling increased its Solventum (SOLV) stake by 2.5% in Q2 2026, buying an estimated $6.13K and bringing the position to 3,472 shares worth $268K. The position accounts for 0.02% of the portfolio, ranked #273.

Howe & Rusling first reported a position in SOLV in Q3 2024 and has held it in 8 quarters since. The position peaked at $268K in Q4 2025. 884 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Howe & Rusling held 3,472 shares of Solventum worth $268K as of Q2 2026.
  • Howe & Rusling bought 84 Solventum shares in Q2 2026, an estimated $6.13K.
  • Solventum made up 0.02% of Howe & Rusling's portfolio in Q2 2026, its #273 holding.
  • Howe & Rusling first reported a position in Solventum in Q3 2024 and has held it in 8 quarters since.
  • Howe & Rusling's Solventum position peaked at $268K in Q4 2025.
  • 884 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Howe & Rusling's 13F filing for Q2 2026, filed 10 Aug 2026.